Curriculum vitae for mark cushman - Purdue College of Pharmacy ...

Mark Cushman
11. Mark S. Cushman and Andrew E. Morrell, "N-Substituted Indenoisoquinolines and
Synthesis Thereof," November 14, 2005, U.S. Provisional Patent Application, Purdue
Reference Number 64473.P1.US, Barnes & Thornburg Attorney Docket Number 3220-
79121.
12. Mark S. Cushman and Bo-Liang Deng, "Alkenyldiarylmethanes, Fused Analogs, and
Syntheses Thereof," November 25, 2005, U.S. Provisional Patent Application, Serial
Number 60/729.838, Purdue Reference Number 64408.P1.US, Barnes & Thornburg
Attorney Docket Number 3220-78445.
13. Mark S. Cushman, John M. Pezzuto, and Arup Maiti, "Chemotherapeutic Flavanoids, and
Synthesis Thereof," December 15, 2006, Purdue Reference Number 64691.P1.US,
Barnes & Thornburg Attorney Docket Number 3220-201177.
14. Mark S. Cushman, Takeshi Sakamoto, Matthew D. Cullen, "Hydrolytically Stable
Alkenyldiarylmethane Non—Nucleoside Reverse Transcriptase Inhibitors," March 29,
2007, Purdue Reference Number 64813.P1.US., Barnes & Thornburg Docket Number
3220-201893.
15. Mark S. Cushman, John M. Pezzuto, and Arup Maiti, "Chemotherapeutic Flavonoids, and
Syntheses Thereof," December 12, 2007, Purdue Reference Number 64681.00.WO, PCT
International Serial No.: PCT/US2007/087283, Barnes & Thornburg Docket Number
3220-204578.
16. Mark S. Cushman, Maris A. Cinelli, Andrew E. Morrell, and Yves G. Pommier,
"Oxobenzindolizinoquinolines and Uses Thereof," May 15, 2008, Purdue Reference
Number 65107.P1.US, U.S. Provisional Patent Application No. 61/053,338, Barnes &
Thornburg Docket Number 3220-205459.
17. Mark S. Cushman, Arup Maiti, and John M. Pezzuto, "Casimiroin, Analogs Thereof, and
Methods for Treating Cancer", Provisional Patent Application No. 61/153807, filed
February 20, 2009.
18. Mark S. Cushman, Yanlei Zheng, Markus Fischer, and Adelbert Bacher, "Riboflavin
Synthase Inhibitors as Potential Antitubercular Agents," U.S. Provisional Patent
Application No. 61/187,464, filed June 16, 2009.
19. Mark S. Cushman, John M. Pezzuto, and B. Sun, "Substituted Stilbenes, Syntheses
Thereof, and Methods of Use in the Treatment and/or Prevention of Cancer". U.S.
Provisional Patent Application No. 61/266,195, filed December 3, 2009.
20. Mark S. Cushman and Arup Maiti, "Casimiroin, Analogs Thereof, and Methods for
Treating Cancer", Provisional Patent Application No. 61/305,582, filed February 18,
2010.
21. Mark S. Cushman and Yunlong Song, "Substituted Norindenoisoquinolines, Synthesis
Thereof, and Methods of their Use," PCT International Application serial no.
PCT/US2011/022732, filed January 27, 2011.
22. Mark S. Cushman and Abdelrahman S. Mayhoub, "Antiviral Thiazoles," United States
Provisional Patent Application 61/441,786, filed February 11, 2011.
23. Mark S. Cushman and Evgeny Kiselev, "Substituted Dibenzonaphthyridines,
Pharmaceutical Uses Thereof and Processes Therefor," Provisional Patent Application
WO 2012/024437 A1, filed August 17, 2011 and published February 23, 2012.
24. Mark S. Cushman and Evgeny Kiselev, "Dibenzo[c,h][1,5]naphthyridinediones as
Topoisomerase I Inhibitors: Design, Synthesis, and Biological Evaluation," filed May
11, 2012.
25. Mark S. Cushman and Katherine E. Peterson, "Alcohol-, Diol-, and Carbohydrate-
Substituted Indenoisoquinolines as Topoisomerase I Inhibitors," PCT/US12/39365, filed
May 24, 2012.
26. Mark S. Cushman, Mohamed Seleem, and Abdelrahman S. Mayhoub, "Antimicrobial
Activity of Novel Substituted Thiazoles against Methicillin-Resistant Staphylococcus
aureus (MRSA)", Application No. 61/720,659, filed October 31, 2012.
24